Cellex Incorporated Information

View Top Employees from Cellex Incorporated

Cellex Incorporated | 439 followers on LinkedIn | Covid-19 | Rapid Test Approved by FDA for EUA Use | Cellex qSARS-CoV-2 IgG/IgM Rapid Test | Founded in 2002, Cellex Incorporated is a biotechnology company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly at point-of-care (POC) settings. On April 1, 2020, Cellex was the first company to receive the Emergency Use Authorization (EUA) for the COVID-19 serology test by the FDA for the qSARS-CoV-2 IgG/IgM Rapid Test. The corporate headquarters are located in Research Triangle Park, North Carolina.

Website	http://www.cellex.us
Revenue	$1 million
Employees	2 (0 on RocketReach)
Founded	2002
Address	76 Tw Alexander Dr, Durham, North Carolina 27709, US
Phone	+1 919-314-5535
Fax	(919) 314-5536
Industry	Medical Devices, Medical Devices & Equipment, Diagnostic Equipment, Research, Manufacturing, Biotechnology
Keywords	Rapid Tests, Rapid Diagnostic Tests, Covid Testing, Antibody Tests, Serological Tests, Point Of Care Diagnostics, Diagnostic Kits, Immunoassay, Infectious Disease Diagnostics, Medical Devices, Diagnostic Instruments, Molecular Diagnostics, Biotechnology, In Vitro Diagnostics, Immunology, Ivd, Healthcare
Competitors	GE HealthCare, Thermo Fisher Scientific, Merck Group, Agilent Technologies, MilliporeSigma, PerkinElmer, Inc., Bio-Rad Laboratories, Eppendorf Group, Tecan, Biosystems LLC +47 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies